Evidence map›Paper›PMID 36227538›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2023

Design and Analysis of Massively Parallel Reporter Assays Using FORECAST.

Pierre-Aurelien Gilliot, Thomas E Gorochowski

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Data hazards in synthetic biology.Synthetic biology (Oxford, England) · 2024
    Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Pierre-Aurelien GilliotSchool of Biological Sciences, University of Bristol, Bristol, UK.
Thomas E GorochowskiSchool of Biological Sciences, University of Bristol, Bristol, UK. thomas.gorochowski@bristol.ac.uk.

Funding

Biotechnology and Biological Sciences Research Council BB/L01386X/1
6 · The paper itself

Abstract

Machine learning is revolutionizing molecular biology and bioengineering by providing powerful insights and predictions. Massively parallel reporter assays (MPRAs) have emerged as a particularly valuable class of high-throughput technique to support such algorithms. MPRAs enable the simultaneous characterization of thousands or even millions of genetic constructs and provide the large amounts of data needed to train models. However, while the scale of this approach is impressive, the design of effective MPRA experiments is challenging due to the many factors that can be varied and the difficulty in predicting how these will impact the quality and quantity of data obtained. Here, we present a computational tool called FORECAST, which can simulate MPRA experiments based on fluorescence-activated cell sorting and subsequent sequencing (commonly referred to as Flow-seq or Sort-seq experiments), as well as carry out rigorous statistical estimation of construct performance from this type of experimental data. FORECAST can be used to develop workflows to aid the design of MPRA experiments and reanalyze existing MPRA data sets.

Indexed as

High-Throughput Nucleotide SequencingSoftwareBiological AssayRegression AnalysisBioinformaticsCell sortingExperimental designInferenceMassively parallel reporter assaySequencingSynthetic biology

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.